Accendra Health Secures Near-Unanimous Consent for Debt Restructuring — Accendra Health, Inc. (Apria, Byram Healthcare)

Event summary

Accendra Health received consents from 99.9% of 2029 Notes holders and 99.2% of 2030 Notes holders to amend indentures, eliminating key covenants and events of default.
The company raised $326.25 million in new senior secured first lien notes, with backstop commitments covering $261 million.
Early exchange results show $478.3 million in 2029 Notes and $547.9 million in 2030 Notes tendered, representing near-total participation.
New notes issued carry significantly higher interest rates (9.000% and 9.750%) compared to existing debt (4.500% and 6.625%).
Early settlement date set for June 15, 2026, with final expiration extended to June 23, 2026.

The big picture

Accendra Health's successful debt restructuring reflects broader trends in healthcare services companies seeking to manage high leverage through covenant-lite structures. The near-unanimous consent highlights bondholder support for the company's strategic pivot, though the significantly higher interest rates suggest increased financial burden. This restructuring positions Accendra Health to navigate potential economic headwinds but at the cost of elevated debt servicing obligations.

What we're watching

Liquidity Dynamics: How the $326.25 million new money issuance will impact Accendra Health's liquidity position and ability to service higher-interest debt.
Covenant Flexibility: Whether the elimination of key covenants provides sufficient operational flexibility or increases financial risk.
Market Reception: The pace at which investors react to the higher interest rates and structural changes in the company's capital stack.